Ensuring Access to Lower-Cost Medicines for Seniors Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in senate (Apr 16, 2026)
Ensuring Access to Lower-Cost Medicines for Seniors Act
This bill requires prescription drug plans under the Medicare prescription drug benefit to include generic drugs and biosimilars on their formularies.
Specifically, the bill requires plans that use formularies to include generic drugs and biosimilars on the formularies and without any requirements (e.g., prior authorization requirements) that are more restrictive as compared to those for brand-name drugs and biologics. Plans that use cost-sharing tiers must also have specific tiers for generic drugs and biosimilars, in accordance with certain limitations.
What just happenedApr 16, 2026
Read twice and referred to the Committee on Finance.
Who’s behind it
- Introduced in SenateApr 16, 2026
- Apr 16, 2026IntroReferral
Read twice and referred to the Committee on Finance.
- Apr 16, 2026IntroReferral10000
Introduced in Senate